α-aminobutyric acid promotes tumor progression by polarizing macrophages through the ASNS–mTORC2 axis
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2606579123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Fei Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 2, Tumor-Associated Macrophages, Macrophages. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Key Research and Development Program of China (NKPs), MOST | National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Tumor-associated macrophages (TAMs), the most abundant immune cell subset in the tumor microenvironment (TME), exhibit phenotypic plasticity and exert critical roles in tumor progression and antitumor immunity. Targeting TAM polarization has emerged as a promising strategy for cancer immunotherapy, yet the key regulators governing this process remain incompletely defined. Here, we identified α-aminobutyric acid (AABA) as a pro-tumor metabolite that drives M2-like polarization of TAMs to promote tumor progression. Mechanistically, AABA binds to asparagine synthetase (ASNS), reinforcing the mTORC2–IRF4 signaling axis to reprogram TAMs, switching macrophage metabolism from glycolysis to oxidative phosphorylation, a hallmark of pro-tumor M2-like phenotypes. Moreover, tumor-derived AABA was transported into macrophages by monocarboxylate transporters 1 and compromised the therapeutic efficacy of PD-1 checkpoint inhibition. Collectively, our findings uncover AABA as a previously unrecognized signaling metabolite to control TAM polarization, providing insights into the metabolic crosstalk within the TME and offering a potential therapeutic target to improve cancer immunotherapy outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
- School of Medical Technology, Jiangsu College of Nursing, Huai'an 223005, Jiangsu, China.
- State Key Laboratory for Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen 361102, China.
- School of Biomedical Sciences, Hunan University, Changsha 410082, China.
- Department of Dermatology, Affiliated Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
ORCID-Profile: Fei Li, Yuting Xia, Xuwei Wu, Lan He, Shu-Hai Lin, Ran He
Förderung
- MOST | National Key Research and Development Program of China (NKPs)
- MOST | National Natural Science Foundation of China (NSFC)
Zitieren
APA
Li, F., Xie, X., Xu, T., Tang, Y., Xia, Y., Tang, Y., Yuan, S., Zhu, M., Wu, X., He, L., Lin, S. H., & He, R. (2026). α-aminobutyric acid promotes tumor progression by polarizing macrophages through the ASNS–mTORC2 axis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2606579123
Vancouver
Li F, Xie X, Xu T, Tang Y, Xia Y, Tang Y, et al. α-aminobutyric acid promotes tumor progression by polarizing macrophages through the ASNS–mTORC2 axis. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2606579123
BibTeX
@article{Li2026,
author = {Li, Fei and Xie, Xiaorong and Xu, Tongran and Tang, Yu and Xia, Yuting and Tang, Yali and Yuan, Shijie and Zhu, Mengdi and Wu, Xuwei and He, Lan and Lin, Shu-Hai and He, Ran},
title = {α-aminobutyric acid promotes tumor progression by polarizing macrophages through the ASNS–mTORC2 axis},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2606579123}
}
EUVIMED